Normal cells can respond to expression of activated oncogenes by initiating cellular
senescence, a permanent state of proliferative arrest. But whether this process reflects a
relevant anticancer mechanism has been debated. Several studies now show that
oncogene-induced senescence can occur in vivo and provides a bona fide barrier to
tumorigenesis.